157 related articles for article (PubMed ID: 32102154)
21. X-linked Recessive Distal Myopathy With Hypertrophic Cardiomyopathy Caused by a Novel Mutation in the FHL1 Gene.
D'Arcy C; Kanellakis V; Forbes R; Wilding B; McGrath M; Howell K; Ryan M; McLean C
J Child Neurol; 2015 Aug; 30(9):1211-7. PubMed ID: 25246303
[TBL] [Abstract][Full Text] [Related]
22. Reducing body myopathy - A new pathogenic FHL1 variant and literature review.
Mota IA; Correia CDC; Fontana PN; Carvalho AAS
Neuromuscul Disord; 2021 Sep; 31(9):847-853. PubMed ID: 34366191
[TBL] [Abstract][Full Text] [Related]
23. Cardiomyopathy and altered integrin-actin signaling in Fhl1 mutant female mice.
Kubota A; Juanola-Falgarona M; Emmanuele V; Sanchez-Quintero MJ; Kariya S; Sera F; Homma S; Tanji K; Quinzii CM; Hirano M
Hum Mol Genet; 2019 Jan; 28(2):209-219. PubMed ID: 30260394
[TBL] [Abstract][Full Text] [Related]
24. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1.
Windpassinger C; Schoser B; Straub V; Hochmeister S; Noor A; Lohberger B; Farra N; Petek E; Schwarzbraun T; Ofner L; Löscher WN; Wagner K; Lochmüller H; Vincent JB; Quasthoff S
Am J Hum Genet; 2008 Jan; 82(1):88-99. PubMed ID: 18179888
[TBL] [Abstract][Full Text] [Related]
25. Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy.
Schessl J; Zou Y; McGrath MJ; Cowling BS; Maiti B; Chin SS; Sewry C; Battini R; Hu Y; Cottle DL; Rosenblatt M; Spruce L; Ganguly A; Kirschner J; Judkins AR; Golden JA; Goebel HH; Muntoni F; Flanigan KM; Mitchell CA; Bönnemann CG
J Clin Invest; 2008 Mar; 118(3):904-12. PubMed ID: 18274675
[TBL] [Abstract][Full Text] [Related]
26. Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy.
Cowling BS; McGrath MJ; Nguyen MA; Cottle DL; Kee AJ; Brown S; Schessl J; Zou Y; Joya J; Bönnemann CG; Hardeman EC; Mitchell CA
J Cell Biol; 2008 Dec; 183(6):1033-48. PubMed ID: 19075112
[TBL] [Abstract][Full Text] [Related]
27. Familial reducing body myopathy with cytoplasmic bodies and rigid spine revisited: identification of a second LIM domain mutation in FHL1.
Schessl J; Columbus A; Hu Y; Zou Y; Voit T; Goebel HH; Bönnemann CG
Neuropediatrics; 2010 Feb; 41(1):43-6. PubMed ID: 20571991
[TBL] [Abstract][Full Text] [Related]
28. Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression.
Wei X; Zhang H
Cancer Biol Med; 2020 May; 17(2):270-281. PubMed ID: 32587768
[TBL] [Abstract][Full Text] [Related]
29. Muscle hypertrophy as the presenting sign in a patient with a complete FHL1 deletion.
Willis TA; Wood CL; Hudson J; Polvikoski T; Barresi R; Lochmüller H; Bushby K; Straub V
Clin Genet; 2016 Aug; 90(2):166-70. PubMed ID: 27409453
[TBL] [Abstract][Full Text] [Related]
30. Rigid spine syndrome caused by a novel mutation in four-and-a-half LIM domain 1 gene (FHL1).
Shalaby S; Hayashi YK; Goto K; Ogawa M; Nonaka I; Noguchi S; Nishino I
Neuromuscul Disord; 2008 Dec; 18(12):959-61. PubMed ID: 18952429
[TBL] [Abstract][Full Text] [Related]
31. Proteomic characterization of aggregate components in an intrafamilial variable FHL1-associated myopathy.
Feldkirchner S; Walter MC; Müller S; Kubny C; Krause S; Kress W; Hanisch FG; Schoser B; Schessl J
Neuromuscul Disord; 2013 May; 23(5):418-26. PubMed ID: 23489660
[TBL] [Abstract][Full Text] [Related]
32. Novel FHL1 mutation variant identified in a patient with nonobstructive hypertrophic cardiomyopathy and myopathy - a case report.
Giucă A; Mitu C; Popescu BO; Bastian AE; Capşa R; Mursă A; Rădoi V; Popescu BA; Jurcuţ R
BMC Med Genet; 2020 Sep; 21(1):188. PubMed ID: 32993534
[TBL] [Abstract][Full Text] [Related]
33. Identification of novel FHL1 mutations associated with X-linked scapuloperoneal myopathy in unrelated Chinese patients.
Lin Y; Ban R; Qiao L; Chen J; Liu M; Liu J; Shi Q
J Hum Genet; 2023 Jul; 68(7):477-484. PubMed ID: 36864287
[TBL] [Abstract][Full Text] [Related]
34. Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy.
Selcen D; Bromberg MB; Chin SS; Engel AG
Neurology; 2011 Nov; 77(22):1951-9. PubMed ID: 22094483
[TBL] [Abstract][Full Text] [Related]
35. Genes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues.
Shathasivam T; Kislinger T; Gramolini AO
J Cell Mol Med; 2010 Dec; 14(12):2702-20. PubMed ID: 20874719
[TBL] [Abstract][Full Text] [Related]
36. FHL1-related clinical, muscle MRI and genetic features in six Chinese patients with reducing body myopathy.
Hu Z; Zhu Y; Liu X; Zhang W; Liu J; Wu S; Xiao J; Yuan Y; Wang Z
J Hum Genet; 2019 Sep; 64(9):919-926. PubMed ID: 31273321
[TBL] [Abstract][Full Text] [Related]
37. Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features.
Cowling BS; Cottle DL; Wilding BR; D'Arcy CE; Mitchell CA; McGrath MJ
Neuromuscul Disord; 2011 Apr; 21(4):237-51. PubMed ID: 21310615
[TBL] [Abstract][Full Text] [Related]
38. Novel FHL1 mutations in fatal and benign reducing body myopathy.
Shalaby S; Hayashi YK; Nonaka I; Noguchi S; Nishino I
Neurology; 2009 Jan; 72(4):375-6. PubMed ID: 19171836
[No Abstract] [Full Text] [Related]
39. Child Neurology: A Case of
Silva AMS; Camelo CG; Matsui-Júnior C; Mendonça RH; Campos LM; Elias AM; Silva CA; Reed UC; Zanoteli E
Neurology; 2021 Mar; 96(9):e1383-e1386. PubMed ID: 33361250
[No Abstract] [Full Text] [Related]
40. Clinical and genetic characteristics of Chinese patients with reducing body myopathy.
Chen L; Lin HX; Yang XX; Chen DF; Dong HL; Yu H; Liu GL; Wu ZY
Neuromuscul Disord; 2021 May; 31(5):442-449. PubMed ID: 33846077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
